These results indicate that the abnormal expression of Sig1R, and its association with β-integrin, affects BEM-mediated BC cell proliferation and angiogenesis by affecting the expression of E2F1, CCNE2, CDK2, PCNA and VEGFA. Here, CDK2 is linked to breast cancer.